KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Trends Analyst Outlook Journalist POV

48 hedge funds and large institutions have $278M invested in KalVista Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

more funds holding

Funds holding: →

14.63% more ownership

Funds ownership: 58.49% → 73.12% (+15%)

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

Holders
48
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$23.4M
2
+$16.8M
3
+$14.4M
4
BI
BVF Inc
California
+$13.5M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$6.75M

Top Sellers

1
-$865K
2
-$545K
3
-$379K
4
DS
DRW Securities
Illinois
-$167K
5
UBS Group
UBS Group
Switzerland
-$52.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$884K
27
$678K
28
$598K
29
$427K
30
$392K
31
$388K
32
$354K
33
$282K
34
$274K
35
$272K
36
$216K
37
$179K
38
$124K
39
$93K
40
$68K
41
$39K
42
$15K
43
$14K
44
$5K
45
$3K
46
$3K
47
$2K
48
$1K
49
–
50
–
1
2
3